Selected research
Market Analysis & Forecast
Global Custom Synthesis and Radiolabeling Market Analysis and Forecast 2026-2032
Market perspective
The global Custom Synthesis and Radiolabeling market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Custom Synthesis and Radiolabeling is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Custom Synthesis and Radiolabeling is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Custom Synthesis and Radiolabeling is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Custom Synthesis and Radiolabeling is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Custom Synthesis and Radiolabeling include Charles River, Eurofins Scientific, PerkinElmer, Sekisui Medical, Eckert & Ziegler, Labcorp, XenoTech (BioIVT), Quotient Sciences and Gifford Bioscience, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Custom Synthesis and Radiolabeling, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Custom Synthesis and Radiolabeling, also provides the revenue of main regions and countries. Of the upcoming market potential for Custom Synthesis and Radiolabeling, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Custom Synthesis and Radiolabeling revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Custom Synthesis and Radiolabeling market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Custom Synthesis and Radiolabeling revenue, projected growth trends, production technology, application and end-user industry.
Custom Synthesis and Radiolabeling Segment by Company
Charles River
Eurofins Scientific
PerkinElmer
Sekisui Medical
Eckert & Ziegler
Labcorp
XenoTech (BioIVT)
Quotient Sciences
Gifford Bioscience
ITM Radiopharma
Almac Group
Accelera
Novandi Chemistry
AptoChem
HMR
AM Chemicals
PolyPeptide Group
NovoPro Bioscience
Institute of Isotopes
Nuvisan
Revvity
Necsa
Fluorizon
Edinburgh Pharmaceutical Processes
Chelatec
Pharmaron
Medicilon
JOINN Laboratories
Frontage
Abace Biotechnology
Beijing Atom High-Tech
Wuxi Beita Pharmatech
Beijing North Institute of Biotechnology
Custom Synthesis and Radiolabeling Segment by Type
C-14
H-3
I-125
Others
Custom Synthesis and Radiolabeling Segment by Application
Drug Discovery
Medical
Others
Custom Synthesis and Radiolabeling Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Synthesis and Radiolabeling market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom Synthesis and Radiolabeling and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Synthesis and Radiolabeling.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Custom Synthesis and Radiolabeling in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Custom Synthesis and Radiolabeling company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Custom Synthesis and Radiolabeling revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
List of Tables
Table 1. Global Custom Synthesis and Radiolabeling Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032
Table 2. C-14 Major Player
Table 3. H-3 Major Player
Table 4. I-125 Major Player
Table 5. Others Major Player
Table 6. Global Custom Synthesis and Radiolabeling Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032
Table 7. Drug Discovery Major Player
Table 8. Medical Major Player
Table 9. Others Major Player
Table 10. Custom Synthesis and Radiolabeling Industry Trends
Table 11. Custom Synthesis and Radiolabeling Industry Drivers
Table 12. Custom Synthesis and Radiolabeling Industry Opportunities and Challenges
Table 13. Custom Synthesis and Radiolabeling Industry Restraints
Table 14. Global Custom Synthesis and Radiolabeling Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032
Table 15. Global Custom Synthesis and Radiolabeling Market Size by Region (2021-2026) & (US$ Million)
Table 16. Global Custom Synthesis and Radiolabeling Market Share by Region (2021-2026)
Table 17. Global Custom Synthesis and Radiolabeling Market Size by Region (2027-2032) & (US$ Million)
Table 18. Global Custom Synthesis and Radiolabeling Market Share by Region (2027-2032)
Table 19. Global Custom Synthesis and Radiolabeling Revenue by Players (US$ Million) & (2021-2026)
Table 20. Global Custom Synthesis and Radiolabeling Revenue Market Share by Players (2021-2026)
Table 21. Global Custom Synthesis and Radiolabeling Key Players Ranking, 2024 VS 2025 VS 2026
Table 22. Global Custom Synthesis and Radiolabeling Key Players Headquarters & Area Served
Table 23. Global Custom Synthesis and Radiolabeling Players, Product Type & Application
Table 24. Global Custom Synthesis and Radiolabeling Players Establishment Date
Table 25. Global Players Market Concentration Ratio (CR5 and HHI)
Table 26. Global Custom Synthesis and Radiolabeling by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 27. Global Custom Synthesis and Radiolabeling Revenue by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 28. Global Custom Synthesis and Radiolabeling Revenue by Type (2021-2026) & (US$ Million)
Table 29. Global Custom Synthesis and Radiolabeling Revenue by Type (2027-2032) & (US$ Million)
Table 30. Global Custom Synthesis and Radiolabeling Revenue Market Share by Type (2021-2026)
Table 31. Global Custom Synthesis and Radiolabeling Revenue Market Share by Type (2027-2032)
Table 32. Global Custom Synthesis and Radiolabeling Revenue by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 33. Global Custom Synthesis and Radiolabeling Revenue by Application (2021-2026) & (US$ Million)
Table 34. Global Custom Synthesis and Radiolabeling Revenue by Application (2027-2032) & (US$ Million)
Table 35. Global Custom Synthesis and Radiolabeling Revenue Market Share by Application (2021-2026)
Table 36. Global Custom Synthesis and Radiolabeling Revenue Market Share by Application (2027-2032)
Table 37. Charles River Company Information
Table 38. Charles River Business Overview
Table 39. Charles River Custom Synthesis and Radiolabeling Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 40. Charles River Custom Synthesis and Radiolabeling Product Portfolio
Table 41. Charles River Recent Development
Table 42. Eurofins Scientific Company Information
Table 43. Eurofins Scientific Business Overview
Table 44. Eurofins Scientific Custom Synthesis and Radiolabeling Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 45. Eurofins Scientific Custom Synthesis and Radiolabeling Product Portfolio
Table 46. Eurofins Scientific Recent Development
Table 47. PerkinElmer Company Information
Table 48. PerkinElmer Business Overview
Table 49. PerkinElmer Custom Synthesis and Radiolabeling Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 50. PerkinElmer Custom Synthesis and Radiolabeling Product Portfolio
Table 51. PerkinElmer Recent Development
Table 52. Sekisui Medical Company Information
Table 53. Sekisui Medical Business Overview
Table 54. Sekisui Medical Custom Synthesis and Radiolabeling Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 55. Sekisui Medical Custom Synthesis and Radiolabeling Product Portfolio
Table 56. Sekisui Medical Recent Development
Table 57. Eckert & Ziegler Company Information
Table 58. Eckert & Ziegler Business Overview
Table 59. Eckert & Ziegler Custom Synthesis and Radiolabeling Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 60. Eckert & Ziegler Custom Synthesis and Radiolabeling Product Portfolio
Table 61. Eckert & Ziegler Recent Development
Table 62. Labcorp Company Information
Table 63. Labcorp Business Overview
Table 64. Labcorp Custom Synthesis and Radiolabeling Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 65. Labcorp Custom Synthesis and Radiolabeling Product Portfolio
Table 66. Labcorp Recent Development
Table 67. XenoTech (BioIVT) Company Information
Table 68. XenoTech (BioIVT) Business Overview
Table 69. XenoTech (BioIVT) Custom Synthesis and Radiolabeling Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 70. XenoTech (BioIVT) Custom Synthesis and Radiolabeling Product Portfolio
Table 71. XenoTech (BioIVT) Recent Development
Table 72. Quotient Sciences Company Information
Table 73. Quotient Sciences Business Overview
Table 74. Quotient Sciences Custom Synthesis and Radiolabeling Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 75. Quotient Sciences Custom Synthesis and Radiolabeling Product Portfolio
Table 76. Quotient Sciences Recent Development
Table 77. Gifford Bioscience Company Information
Table 78. Gifford Bioscience Business Overview
Table 79. Gifford Bioscience Custom Synthesis and Radiolabeling Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 80. Gifford Bioscience Custom Synthesis and Radiolabeling Product Portfolio
Table 81. Gifford Bioscience Recent Development
Table 82. ITM Radiopharma Company Information
Table 83. ITM Radiopharma Business Overview
Table 84. ITM Radiopharma Custom Synthesis and Radiolabeling Revenue and Gross Margin (US$ Million) & (2021-2026)
Table 85. ITM Radiopharma Custom Synthesis and Radiolabeling Product Portfolio
Table 86. ITM Radiopharma Recent Development
Table 87. Almac Group Company Information
Table 88. Almac Group Business Overview
Table 89. Almac Group Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 90. Almac Group Custom Synthesis and Radiolabeling Product Portfolio
Table 91. Almac Group Recent Development
Table 92. Accelera Company Information
Table 93. Accelera Business Overview
Table 94. Accelera Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 95. Accelera Custom Synthesis and Radiolabeling Product Portfolio
Table 96. Accelera Recent Development
Table 97. Novandi Chemistry Company Information
Table 98. Novandi Chemistry Business Overview
Table 99. Novandi Chemistry Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 100. Novandi Chemistry Custom Synthesis and Radiolabeling Product Portfolio
Table 101. Novandi Chemistry Recent Development
Table 102. AptoChem Company Information
Table 103. AptoChem Business Overview
Table 104. AptoChem Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 105. AptoChem Custom Synthesis and Radiolabeling Product Portfolio
Table 106. AptoChem Recent Development
Table 107. HMR Company Information
Table 108. HMR Business Overview
Table 109. HMR Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 110. HMR Custom Synthesis and Radiolabeling Product Portfolio
Table 111. HMR Recent Development
Table 112. AM Chemicals Company Information
Table 113. AM Chemicals Business Overview
Table 114. AM Chemicals Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 115. AM Chemicals Custom Synthesis and Radiolabeling Product Portfolio
Table 116. AM Chemicals Recent Development
Table 117. PolyPeptide Group Company Information
Table 118. PolyPeptide Group Business Overview
Table 119. PolyPeptide Group Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 120. PolyPeptide Group Custom Synthesis and Radiolabeling Product Portfolio
Table 121. PolyPeptide Group Recent Development
Table 122. NovoPro Bioscience Company Information
Table 123. NovoPro Bioscience Business Overview
Table 124. NovoPro Bioscience Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 125. NovoPro Bioscience Custom Synthesis and Radiolabeling Product Portfolio
Table 126. NovoPro Bioscience Recent Development
Table 127. Institute of Isotopes Company Information
Table 128. Institute of Isotopes Business Overview
Table 129. Institute of Isotopes Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 130. Institute of Isotopes Custom Synthesis and Radiolabeling Product Portfolio
Table 131. Institute of Isotopes Recent Development
Table 132. Nuvisan Company Information
Table 133. Nuvisan Business Overview
Table 134. Nuvisan Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 135. Nuvisan Custom Synthesis and Radiolabeling Product Portfolio
Table 136. Nuvisan Recent Development
Table 137. Revvity Company Information
Table 138. Revvity Business Overview
Table 139. Revvity Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 140. Revvity Custom Synthesis and Radiolabeling Product Portfolio
Table 141. Revvity Recent Development
Table 142. Necsa Company Information
Table 143. Necsa Business Overview
Table 144. Necsa Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 145. Necsa Custom Synthesis and Radiolabeling Product Portfolio
Table 146. Necsa Recent Development
Table 147. Fluorizon Company Information
Table 148. Fluorizon Business Overview
Table 149. Fluorizon Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 150. Fluorizon Custom Synthesis and Radiolabeling Product Portfolio
Table 151. Fluorizon Recent Development
Table 152. Edinburgh Pharmaceutical Processes Company Information
Table 153. Edinburgh Pharmaceutical Processes Business Overview
Table 154. Edinburgh Pharmaceutical Processes Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 155. Edinburgh Pharmaceutical Processes Custom Synthesis and Radiolabeling Product Portfolio
Table 156. Edinburgh Pharmaceutical Processes Recent Development
Table 157. Chelatec Company Information
Table 158. Chelatec Business Overview
Table 159. Chelatec Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 160. Chelatec Custom Synthesis and Radiolabeling Product Portfolio
Table 161. Chelatec Recent Development
Table 162. Pharmaron Company Information
Table 163. Pharmaron Business Overview
Table 164. Pharmaron Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 165. Pharmaron Custom Synthesis and Radiolabeling Product Portfolio
Table 166. Pharmaron Recent Development
Table 167. Medicilon Company Information
Table 168. Medicilon Business Overview
Table 169. Medicilon Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 170. Medicilon Custom Synthesis and Radiolabeling Product Portfolio
Table 171. Medicilon Recent Development
Table 172. JOINN Laboratories Company Information
Table 173. JOINN Laboratories Business Overview
Table 174. JOINN Laboratories Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 175. JOINN Laboratories Custom Synthesis and Radiolabeling Product Portfolio
Table 176. JOINN Laboratories Recent Development
Table 177. Frontage Company Information
Table 178. Frontage Business Overview
Table 179. Frontage Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 180. Frontage Custom Synthesis and Radiolabeling Product Portfolio
Table 181. Frontage Recent Development
Table 182. Abace Biotechnology Company Information
Table 183. Abace Biotechnology Business Overview
Table 184. Abace Biotechnology Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 185. Abace Biotechnology Custom Synthesis and Radiolabeling Product Portfolio
Table 186. Abace Biotechnology Recent Development
Table 187. Beijing Atom High-Tech Company Information
Table 188. Beijing Atom High-Tech Business Overview
Table 189. Beijing Atom High-Tech Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 190. Beijing Atom High-Tech Custom Synthesis and Radiolabeling Product Portfolio
Table 191. Beijing Atom High-Tech Recent Development
Table 192. Wuxi Beita Pharmatech Company Information
Table 193. Wuxi Beita Pharmatech Business Overview
Table 194. Wuxi Beita Pharmatech Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 195. Wuxi Beita Pharmatech Custom Synthesis and Radiolabeling Product Portfolio
Table 196. Wuxi Beita Pharmatech Recent Development
Table 197. Beijing North Institute of Biotechnology Company Information
Table 198. Beijing North Institute of Biotechnology Business Overview
Table 199. Beijing North Institute of Biotechnology Custom Synthesis and Radiolabeling Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 200. Beijing North Institute of Biotechnology Custom Synthesis and Radiolabeling Product Portfolio
Table 201. Beijing North Institute of Biotechnology Recent Development
Table 202. North America Custom Synthesis and Radiolabeling Revenue by Type (2021-2026) & (US$ Million)
Table 203. North America Custom Synthesis and Radiolabeling Revenue by Type (2027-2032) & (US$ Million)
Table 204. North America Custom Synthesis and Radiolabeling Revenue by Application (2021-2026) & (US$ Million)
Table 205. North America Custom Synthesis and Radiolabeling Revenue by Application (2027-2032) & (US$ Million)
Table 206. North America Custom Synthesis and Radiolabeling Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 207. North America Custom Synthesis and Radiolabeling Revenue by Country (2021-2026) & (US$ Million)
Table 208. North America Custom Synthesis and Radiolabeling Revenue by Country (US$ Million) & (2027-2032)
Table 209. Europe Custom Synthesis and Radiolabeling Revenue by Type (2021-2026) & (US$ Million)
Table 210. Europe Custom Synthesis and Radiolabeling Revenue by Type (2027-2032) & (US$ Million)
Table 211. Europe Custom Synthesis and Radiolabeling Revenue by Application (2021-2026) & (US$ Million)
Table 212. Europe Custom Synthesis and Radiolabeling Revenue by Application (2027-2032) & (US$ Million)
Table 213. Europe Custom Synthesis and Radiolabeling Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 214. Europe Custom Synthesis and Radiolabeling Revenue by Country (2021-2026) & (US$ Million)
Table 215. Europe Custom Synthesis and Radiolabeling Revenue by Country (US$ Million) & (2027-2032)
Table 216. China Custom Synthesis and Radiolabeling Revenue by Type (2021-2026) & (US$ Million)
Table 217. China Custom Synthesis and Radiolabeling Revenue by Type (2027-2032) & (US$ Million)
Table 218. China Custom Synthesis and Radiolabeling Revenue by Application (2021-2026) & (US$ Million)
Table 219. China Custom Synthesis and Radiolabeling Revenue by Application (2027-2032) & (US$ Million)
Table 220. Asia Custom Synthesis and Radiolabeling Revenue by Type (2021-2026) & (US$ Million)
Table 221. Asia Custom Synthesis and Radiolabeling Revenue by Type (2027-2032) & (US$ Million)
Table 222. Asia Custom Synthesis and Radiolabeling Revenue by Application (2021-2026) & (US$ Million)
Table 223. Asia Custom Synthesis and Radiolabeling Revenue by Application (2027-2032) & (US$ Million)
Table 224. Asia Custom Synthesis and Radiolabeling Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million)
Table 225. Asia Custom Synthesis and Radiolabeling Revenue by Region (US$ Million) & (2021-2026)
Table 226. Asia Custom Synthesis and Radiolabeling Revenue by Region (US$ Million) & (2027-2032)
Table 227. SAMEA Custom Synthesis and Radiolabeling Revenue by Type (2021-2026) & (US$ Million)
Table 228. SAMEA Custom Synthesis and Radiolabeling Revenue by Type (2027-2032) & (US$ Million)
Table 229. SAMEA Custom Synthesis and Radiolabeling Revenue by Application (2021-2026) & (US$ Million)
Table 230. SAMEA Custom Synthesis and Radiolabeling Revenue by Application (2027-2032) & (US$ Million)
Table 231. SAMEA Custom Synthesis and Radiolabeling Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million)
Table 232. SAMEA Custom Synthesis and Radiolabeling Revenue by Country (2021-2026) & (US$ Million)
Table 233. SAMEA Custom Synthesis and Radiolabeling Revenue by Country (US$ Million) & (2027-2032)
Table 234. Research Programs/Design for This Report
Table 235. Authors List of This Report
Table 236. Secondary Sources
Table 237. Primary Sources
List of Figures
Figure 1. Custom Synthesis and Radiolabeling Image
Figure 2. Global Custom Synthesis and Radiolabeling Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Custom Synthesis and Radiolabeling Market Size Share 2021 VS 2025 VS 2032
Figure 4. C-14 Image
Figure 5. H-3 Image
Figure 6. I-125 Image
Figure 7. Others Image
Figure 8. Global Custom Synthesis and Radiolabeling Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032
Figure 9. Global Custom Synthesis and Radiolabeling Market Size Share 2021 VS 2025 VS 2032
Figure 10. Drug Discovery Image
Figure 11. Medical Image
Figure 12. Others Image
Figure 13. Global Custom Synthesis and Radiolabeling Market Size (US$ Million) & (2021-2032)
Figure 14. Global Custom Synthesis and Radiolabeling Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 15. Global Custom Synthesis and Radiolabeling Market Share by Region: 2021 VS 2025 VS 2032
Figure 16. Global Custom Synthesis and Radiolabeling Players Revenue Share Top 10 and Top 5 in 2025
Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 18. Global Custom Synthesis and Radiolabeling Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 19. Global Custom Synthesis and Radiolabeling Revenue Market Share 2021 VS 2025 VS 2032
Figure 20. Global Custom Synthesis and Radiolabeling Revenue Market Share by Type (2021-2032)
Figure 21. Global Custom Synthesis and Radiolabeling Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 22. Global Custom Synthesis and Radiolabeling Revenue Market Share by Application (2021 VS 2025 VS 2032)
Figure 23. Global Custom Synthesis and Radiolabeling Revenue Market Share by Application (2021-2032)
Figure 24. North America Custom Synthesis and Radiolabeling Revenue YoY Growth (2021-2032) & (US$ Million)
Figure 25. North America Custom Synthesis and Radiolabeling Revenue Share by Type (2021-2032)
Figure 26. North America Custom Synthesis and Radiolabeling Revenue Share by Application (2021-2032)
Figure 27. North America Custom Synthesis and Radiolabeling Revenue Share by Country (2021-2032)
Figure 28. United States Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 29. Canada Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 30. Mexico Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 31. Europe Custom Synthesis and Radiolabeling Revenue YoY Growth (2021-2032) & (US$ Million)
Figure 32. Europe Custom Synthesis and Radiolabeling Revenue Share by Type (2021-2032)
Figure 33. Europe Custom Synthesis and Radiolabeling Revenue Share by Application (2021-2032)
Figure 34. Europe Custom Synthesis and Radiolabeling Revenue Share by Country (2021-2032)
Figure 35. Germany Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 36. France Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 37. U.K. Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 38. Italy Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 39. Spain Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 40. Russia Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 41. Netherlands Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 42. Nordic Countries Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 43. China Custom Synthesis and Radiolabeling Revenue YoY Growth (2021-2032) & (US$ Million)
Figure 44. China Custom Synthesis and Radiolabeling Revenue Share by Type (2021-2032)
Figure 45. China Custom Synthesis and Radiolabeling Revenue Share by Application (2021-2032)
Figure 46. Asia Custom Synthesis and Radiolabeling Revenue YoY Growth (2021-2032) & (US$ Million)
Figure 47. Asia Custom Synthesis and Radiolabeling Revenue Share by Type (2021-2032)
Figure 48. Asia Custom Synthesis and Radiolabeling Revenue Share by Application (2021-2032)
Figure 49. Asia Custom Synthesis and Radiolabeling Revenue Share by Region (2021-2032)
Figure 50. Japan Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 51. South Korea Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 52. India Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 53. Australia Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 54. Taiwan Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 55. Southeast Asia Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 56. SAMEA Custom Synthesis and Radiolabeling Revenue YoY Growth (2021-2032) & (US$ Million)
Figure 57. SAMEA Custom Synthesis and Radiolabeling Revenue Share by Type (2021-2032)
Figure 58. SAMEA Custom Synthesis and Radiolabeling Revenue Share by Application (2021-2032)
Figure 59. SAMEA Custom Synthesis and Radiolabeling Revenue Share by Country (2021-2032)
Figure 60. Brazil Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 61. Argentina Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 62. Chile Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 63. Colombia Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 64. Peru Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 65. Saudi Arabia Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 66. Israel Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 67. UAE Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 68. Turkey Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 69. Iran Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 70. Egypt Custom Synthesis and Radiolabeling Revenue YoY Growth (US$ Million) & (2021-2032)
Figure 71. Years Considered
Figure 72. Research Process
Figure 73. Key Executives Interviewed
Scope & coverage.
Types
- C-14
- H-3
- I-125
- Others
Applications
- Drug Discovery
- Medical
- Others
Companies covered
- Charles River
- Eurofins Scientific
- PerkinElmer
- Sekisui Medical
- Eckert & Ziegler
- Labcorp
- XenoTech (BioIVT)
- Quotient Sciences
- Gifford Bioscience
- ITM Radiopharma
- Almac Group
- Accelera
- Novandi Chemistry
- AptoChem
- HMR
- AM Chemicals
- PolyPeptide Group
- NovoPro Bioscience
- Institute of Isotopes
- Nuvisan
- Revvity
- Necsa
- Fluorizon
- Edinburgh Pharmaceutical Processes
- Chelatec
- Pharmaron
- Medicilon
- JOINN Laboratories
- Frontage
- Abace Biotechnology
- Beijing Atom High-Tech
- Wuxi Beita Pharmatech
- Beijing North Institute of Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Custom Synthesis and Radiolabeling Market by Type
- 1.2.1 Global Custom Synthesis and Radiolabeling Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 C-14
- 1.2.3 H-3
- 1.2.4 I-125
- 1.2.5 Others
- 1.3 Custom Synthesis and Radiolabeling Market by Application
- 1.3.1 Global Custom Synthesis and Radiolabeling Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Drug Discovery
- 1.3.3 Medical
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Custom Synthesis and Radiolabeling Market Dynamics
- 2.1 Custom Synthesis and Radiolabeling Industry Trends
- 2.2 Custom Synthesis and Radiolabeling Industry Drivers
- 2.3 Custom Synthesis and Radiolabeling Industry Opportunities and Challenges
- 2.4 Custom Synthesis and Radiolabeling Industry Restraints
3 Global Growth Perspective
- 3.1 Global Custom Synthesis and Radiolabeling Market Perspective (2021-2032)
- 3.2 Global Custom Synthesis and Radiolabeling Growth Trends by Region
- 3.2.1 Global Custom Synthesis and Radiolabeling Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Custom Synthesis and Radiolabeling Market Size by Region (2021-2026)
- 3.2.3 Global Custom Synthesis and Radiolabeling Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Custom Synthesis and Radiolabeling Revenue by Players
- 4.1.1 Global Custom Synthesis and Radiolabeling Revenue by Players (2021-2026)
- 4.1.2 Global Custom Synthesis and Radiolabeling Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Custom Synthesis and Radiolabeling Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Custom Synthesis and Radiolabeling Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Custom Synthesis and Radiolabeling Key Players Headquarters & Area Served
- 4.4 Global Custom Synthesis and Radiolabeling Players, Product Type & Application
- 4.5 Global Custom Synthesis and Radiolabeling Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Custom Synthesis and Radiolabeling Market CR5 and HHI
- 4.6.3 2025 Custom Synthesis and Radiolabeling Tier 1, Tier 2, and Tier 3
5 Custom Synthesis and Radiolabeling Market Size by Type
- 5.1 Global Custom Synthesis and Radiolabeling Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Custom Synthesis and Radiolabeling Revenue by Type (2021-2032)
- 5.3 Global Custom Synthesis and Radiolabeling Revenue Market Share by Type (2021-2032)
6 Custom Synthesis and Radiolabeling Market Size by Application
- 6.1 Global Custom Synthesis and Radiolabeling Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Custom Synthesis and Radiolabeling Revenue by Application (2021-2032)
- 6.3 Global Custom Synthesis and Radiolabeling Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Charles River
- 7.1.1 Charles River Company Information
- 7.1.2 Charles River Business Overview
- 7.1.3 Charles River Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.1.4 Charles River Custom Synthesis and Radiolabeling Product Portfolio
- 7.1.5 Charles River Recent Developments
- 7.2 Eurofins Scientific
- 7.2.1 Eurofins Scientific Company Information
- 7.2.2 Eurofins Scientific Business Overview
- 7.2.3 Eurofins Scientific Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.2.4 Eurofins Scientific Custom Synthesis and Radiolabeling Product Portfolio
- 7.2.5 Eurofins Scientific Recent Developments
- 7.3 PerkinElmer
- 7.3.1 PerkinElmer Company Information
- 7.3.2 PerkinElmer Business Overview
- 7.3.3 PerkinElmer Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.3.4 PerkinElmer Custom Synthesis and Radiolabeling Product Portfolio
- 7.3.5 PerkinElmer Recent Developments
- 7.4 Sekisui Medical
- 7.4.1 Sekisui Medical Company Information
- 7.4.2 Sekisui Medical Business Overview
- 7.4.3 Sekisui Medical Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.4.4 Sekisui Medical Custom Synthesis and Radiolabeling Product Portfolio
- 7.4.5 Sekisui Medical Recent Developments
- 7.5 Eckert & Ziegler
- 7.5.1 Eckert & Ziegler Company Information
- 7.5.2 Eckert & Ziegler Business Overview
- 7.5.3 Eckert & Ziegler Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.5.4 Eckert & Ziegler Custom Synthesis and Radiolabeling Product Portfolio
- 7.5.5 Eckert & Ziegler Recent Developments
- 7.6 Labcorp
- 7.6.1 Labcorp Company Information
- 7.6.2 Labcorp Business Overview
- 7.6.3 Labcorp Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.6.4 Labcorp Custom Synthesis and Radiolabeling Product Portfolio
- 7.6.5 Labcorp Recent Developments
- 7.7 XenoTech (BioIVT)
- 7.7.1 XenoTech (BioIVT) Company Information
- 7.7.2 XenoTech (BioIVT) Business Overview
- 7.7.3 XenoTech (BioIVT) Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.7.4 XenoTech (BioIVT) Custom Synthesis and Radiolabeling Product Portfolio
- 7.7.5 XenoTech (BioIVT) Recent Developments
- 7.8 Quotient Sciences
- 7.8.1 Quotient Sciences Company Information
- 7.8.2 Quotient Sciences Business Overview
- 7.8.3 Quotient Sciences Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.8.4 Quotient Sciences Custom Synthesis and Radiolabeling Product Portfolio
- 7.8.5 Quotient Sciences Recent Developments
- 7.9 Gifford Bioscience
- 7.9.1 Gifford Bioscience Company Information
- 7.9.2 Gifford Bioscience Business Overview
- 7.9.3 Gifford Bioscience Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.9.4 Gifford Bioscience Custom Synthesis and Radiolabeling Product Portfolio
- 7.9.5 Gifford Bioscience Recent Developments
- 7.10 ITM Radiopharma
- 7.10.1 ITM Radiopharma Company Information
- 7.10.2 ITM Radiopharma Business Overview
- 7.10.3 ITM Radiopharma Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.10.4 ITM Radiopharma Custom Synthesis and Radiolabeling Product Portfolio
- 7.10.5 ITM Radiopharma Recent Developments
- 7.11 Almac Group
- 7.11.1 Almac Group Company Information
- 7.11.2 Almac Group Business Overview
- 7.11.3 Almac Group Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.11.4 Almac Group Custom Synthesis and Radiolabeling Product Portfolio
- 7.11.5 Almac Group Recent Developments
- 7.12 Accelera
- 7.12.1 Accelera Company Information
- 7.12.2 Accelera Business Overview
- 7.12.3 Accelera Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.12.4 Accelera Custom Synthesis and Radiolabeling Product Portfolio
- 7.12.5 Accelera Recent Developments
- 7.13 Novandi Chemistry
- 7.13.1 Novandi Chemistry Company Information
- 7.13.2 Novandi Chemistry Business Overview
- 7.13.3 Novandi Chemistry Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.13.4 Novandi Chemistry Custom Synthesis and Radiolabeling Product Portfolio
- 7.13.5 Novandi Chemistry Recent Developments
- 7.14 AptoChem
- 7.14.1 AptoChem Company Information
- 7.14.2 AptoChem Business Overview
- 7.14.3 AptoChem Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.14.4 AptoChem Custom Synthesis and Radiolabeling Product Portfolio
- 7.14.5 AptoChem Recent Developments
- 7.15 HMR
- 7.15.1 HMR Company Information
- 7.15.2 HMR Business Overview
- 7.15.3 HMR Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.15.4 HMR Custom Synthesis and Radiolabeling Product Portfolio
- 7.15.5 HMR Recent Developments
- 7.16 AM Chemicals
- 7.16.1 AM Chemicals Company Information
- 7.16.2 AM Chemicals Business Overview
- 7.16.3 AM Chemicals Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.16.4 AM Chemicals Custom Synthesis and Radiolabeling Product Portfolio
- 7.16.5 AM Chemicals Recent Developments
- 7.17 PolyPeptide Group
- 7.17.1 PolyPeptide Group Company Information
- 7.17.2 PolyPeptide Group Business Overview
- 7.17.3 PolyPeptide Group Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.17.4 PolyPeptide Group Custom Synthesis and Radiolabeling Product Portfolio
- 7.17.5 PolyPeptide Group Recent Developments
- 7.18 NovoPro Bioscience
- 7.18.1 NovoPro Bioscience Company Information
- 7.18.2 NovoPro Bioscience Business Overview
- 7.18.3 NovoPro Bioscience Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.18.4 NovoPro Bioscience Custom Synthesis and Radiolabeling Product Portfolio
- 7.18.5 NovoPro Bioscience Recent Developments
- 7.19 Institute of Isotopes
- 7.19.1 Institute of Isotopes Company Information
- 7.19.2 Institute of Isotopes Business Overview
- 7.19.3 Institute of Isotopes Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.19.4 Institute of Isotopes Custom Synthesis and Radiolabeling Product Portfolio
- 7.19.5 Institute of Isotopes Recent Developments
- 7.20 Nuvisan
- 7.20.1 Nuvisan Company Information
- 7.20.2 Nuvisan Business Overview
- 7.20.3 Nuvisan Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.20.4 Nuvisan Custom Synthesis and Radiolabeling Product Portfolio
- 7.20.5 Nuvisan Recent Developments
- 7.21 Revvity
- 7.21.1 Revvity Company Information
- 7.21.2 Revvity Business Overview
- 7.21.3 Revvity Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.21.4 Revvity Custom Synthesis and Radiolabeling Product Portfolio
- 7.21.5 Revvity Recent Developments
- 7.22 Necsa
- 7.22.1 Necsa Company Information
- 7.22.2 Necsa Business Overview
- 7.22.3 Necsa Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.22.4 Necsa Custom Synthesis and Radiolabeling Product Portfolio
- 7.22.5 Necsa Recent Developments
- 7.23 Fluorizon
- 7.23.1 Fluorizon Company Information
- 7.23.2 Fluorizon Business Overview
- 7.23.3 Fluorizon Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.23.4 Fluorizon Custom Synthesis and Radiolabeling Product Portfolio
- 7.23.5 Fluorizon Recent Developments
- 7.24 Edinburgh Pharmaceutical Processes
- 7.24.1 Edinburgh Pharmaceutical Processes Company Information
- 7.24.2 Edinburgh Pharmaceutical Processes Business Overview
- 7.24.3 Edinburgh Pharmaceutical Processes Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.24.4 Edinburgh Pharmaceutical Processes Custom Synthesis and Radiolabeling Product Portfolio
- 7.24.5 Edinburgh Pharmaceutical Processes Recent Developments
- 7.25 Chelatec
- 7.25.1 Chelatec Company Information
- 7.25.2 Chelatec Business Overview
- 7.25.3 Chelatec Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.25.4 Chelatec Custom Synthesis and Radiolabeling Product Portfolio
- 7.25.5 Chelatec Recent Developments
- 7.26 Pharmaron
- 7.26.1 Pharmaron Company Information
- 7.26.2 Pharmaron Business Overview
- 7.26.3 Pharmaron Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.26.4 Pharmaron Custom Synthesis and Radiolabeling Product Portfolio
- 7.26.5 Pharmaron Recent Developments
- 7.27 Medicilon
- 7.27.1 Medicilon Company Information
- 7.27.2 Medicilon Business Overview
- 7.27.3 Medicilon Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.27.4 Medicilon Custom Synthesis and Radiolabeling Product Portfolio
- 7.27.5 Medicilon Recent Developments
- 7.28 JOINN Laboratories
- 7.28.1 JOINN Laboratories Company Information
- 7.28.2 JOINN Laboratories Business Overview
- 7.28.3 JOINN Laboratories Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.28.4 JOINN Laboratories Custom Synthesis and Radiolabeling Product Portfolio
- 7.28.5 JOINN Laboratories Recent Developments
- 7.29 Frontage
- 7.29.1 Frontage Company Information
- 7.29.2 Frontage Business Overview
- 7.29.3 Frontage Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.29.4 Frontage Custom Synthesis and Radiolabeling Product Portfolio
- 7.29.5 Frontage Recent Developments
- 7.30 Abace Biotechnology
- 7.30.1 Abace Biotechnology Company Information
- 7.30.2 Abace Biotechnology Business Overview
- 7.30.3 Abace Biotechnology Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.30.4 Abace Biotechnology Custom Synthesis and Radiolabeling Product Portfolio
- 7.30.5 Abace Biotechnology Recent Developments
- 7.31 Beijing Atom High-Tech
- 7.31.1 Beijing Atom High-Tech Company Information
- 7.31.2 Beijing Atom High-Tech Business Overview
- 7.31.3 Beijing Atom High-Tech Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.31.4 Beijing Atom High-Tech Custom Synthesis and Radiolabeling Product Portfolio
- 7.31.5 Beijing Atom High-Tech Recent Developments
- 7.32 Wuxi Beita Pharmatech
- 7.32.1 Wuxi Beita Pharmatech Company Information
- 7.32.2 Wuxi Beita Pharmatech Business Overview
- 7.32.3 Wuxi Beita Pharmatech Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.32.4 Wuxi Beita Pharmatech Custom Synthesis and Radiolabeling Product Portfolio
- 7.32.5 Wuxi Beita Pharmatech Recent Developments
- 7.33 Beijing North Institute of Biotechnology
- 7.33.1 Beijing North Institute of Biotechnology Company Information
- 7.33.2 Beijing North Institute of Biotechnology Business Overview
- 7.33.3 Beijing North Institute of Biotechnology Custom Synthesis and Radiolabeling Revenue and Gross Margin (2021-2026)
- 7.33.4 Beijing North Institute of Biotechnology Custom Synthesis and Radiolabeling Product Portfolio
- 7.33.5 Beijing North Institute of Biotechnology Recent Developments
8 North America
- 8.1 North America Custom Synthesis and Radiolabeling Revenue (2021-2032)
- 8.2 North America Custom Synthesis and Radiolabeling Revenue by Type (2021-2032)
- 8.2.1 North America Custom Synthesis and Radiolabeling Revenue by Type (2021-2026)
- 8.2.2 North America Custom Synthesis and Radiolabeling Revenue by Type (2027-2032)
- 8.3 North America Custom Synthesis and Radiolabeling Revenue Share by Type (2021-2032)
- 8.4 North America Custom Synthesis and Radiolabeling Revenue by Application (2021-2032)
- 8.4.1 North America Custom Synthesis and Radiolabeling Revenue by Application (2021-2026)
- 8.4.2 North America Custom Synthesis and Radiolabeling Revenue by Application (2027-2032)
- 8.5 North America Custom Synthesis and Radiolabeling Revenue Share by Application (2021-2032)
- 8.6 North America Custom Synthesis and Radiolabeling Revenue by Country
- 8.6.1 North America Custom Synthesis and Radiolabeling Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Custom Synthesis and Radiolabeling Revenue by Country (2021-2026)
- 8.6.3 North America Custom Synthesis and Radiolabeling Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Custom Synthesis and Radiolabeling Revenue (2021-2032)
- 9.2 Europe Custom Synthesis and Radiolabeling Revenue by Type (2021-2032)
- 9.2.1 Europe Custom Synthesis and Radiolabeling Revenue by Type (2021-2026)
- 9.2.2 Europe Custom Synthesis and Radiolabeling Revenue by Type (2027-2032)
- 9.3 Europe Custom Synthesis and Radiolabeling Revenue Share by Type (2021-2032)
- 9.4 Europe Custom Synthesis and Radiolabeling Revenue by Application (2021-2032)
- 9.4.1 Europe Custom Synthesis and Radiolabeling Revenue by Application (2021-2026)
- 9.4.2 Europe Custom Synthesis and Radiolabeling Revenue by Application (2027-2032)
- 9.5 Europe Custom Synthesis and Radiolabeling Revenue Share by Application (2021-2032)
- 9.6 Europe Custom Synthesis and Radiolabeling Revenue by Country
- 9.6.1 Europe Custom Synthesis and Radiolabeling Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Custom Synthesis and Radiolabeling Revenue by Country (2021-2026)
- 9.6.3 Europe Custom Synthesis and Radiolabeling Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Custom Synthesis and Radiolabeling Revenue (2021-2032)
- 10.2 China Custom Synthesis and Radiolabeling Revenue by Type (2021-2032)
- 10.2.1 China Custom Synthesis and Radiolabeling Revenue by Type (2021-2026)
- 10.2.2 China Custom Synthesis and Radiolabeling Revenue by Type (2027-2032)
- 10.3 China Custom Synthesis and Radiolabeling Revenue Share by Type (2021-2032)
- 10.4 China Custom Synthesis and Radiolabeling Revenue by Application (2021-2032)
- 10.4.1 China Custom Synthesis and Radiolabeling Revenue by Application (2021-2026)
- 10.4.2 China Custom Synthesis and Radiolabeling Revenue by Application (2027-2032)
- 10.5 China Custom Synthesis and Radiolabeling Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Custom Synthesis and Radiolabeling Revenue (2021-2032)
- 11.2 Asia Custom Synthesis and Radiolabeling Revenue by Type (2021-2032)
- 11.2.1 Asia Custom Synthesis and Radiolabeling Revenue by Type (2021-2026)
- 11.2.2 Asia Custom Synthesis and Radiolabeling Revenue by Type (2027-2032)
- 11.3 Asia Custom Synthesis and Radiolabeling Revenue Share by Type (2021-2032)
- 11.4 Asia Custom Synthesis and Radiolabeling Revenue by Application (2021-2032)
- 11.4.1 Asia Custom Synthesis and Radiolabeling Revenue by Application (2021-2026)
- 11.4.2 Asia Custom Synthesis and Radiolabeling Revenue by Application (2027-2032)
- 11.5 Asia Custom Synthesis and Radiolabeling Revenue Share by Application (2021-2032)
- 11.6 Asia Custom Synthesis and Radiolabeling Revenue by Country
- 11.6.1 Asia Custom Synthesis and Radiolabeling Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Custom Synthesis and Radiolabeling Revenue by Country (2021-2026)
- 11.6.3 Asia Custom Synthesis and Radiolabeling Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Custom Synthesis and Radiolabeling Revenue (2021-2032)
- 12.2 SAMEA Custom Synthesis and Radiolabeling Revenue by Type (2021-2032)
- 12.2.1 SAMEA Custom Synthesis and Radiolabeling Revenue by Type (2021-2026)
- 12.2.2 SAMEA Custom Synthesis and Radiolabeling Revenue by Type (2027-2032)
- 12.3 SAMEA Custom Synthesis and Radiolabeling Revenue Share by Type (2021-2032)
- 12.4 SAMEA Custom Synthesis and Radiolabeling Revenue by Application (2021-2032)
- 12.4.1 SAMEA Custom Synthesis and Radiolabeling Revenue by Application (2021-2026)
- 12.4.2 SAMEA Custom Synthesis and Radiolabeling Revenue by Application (2027-2032)
- 12.5 SAMEA Custom Synthesis and Radiolabeling Revenue Share by Application (2021-2032)
- 12.6 SAMEA Custom Synthesis and Radiolabeling Revenue by Country
- 12.6.1 SAMEA Custom Synthesis and Radiolabeling Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Custom Synthesis and Radiolabeling Revenue by Country (2021-2026)
- 12.6.3 SAMEA Custom Synthesis and Radiolabeling Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst